CD30-mediated signaling has costimulatory effects in T and B cells, and serum levels of soluble CD30 serve as a prognostic marker of Hodgkin's disease and acquired immunodeficiency syndrome (246–248). This evidence concerns the gene TNFRSF8 and Hodgkins lymphoma.